世界のバイオテクノロジー機器市場規模は2028年までに1,067億5,000万米ドルに達する見込みです。同市場は、2021年から2028年にかけて、12.66%のCAGRで拡大すると予測されています。市場は、技術の進歩、レーザー治療によって提供される利点、標的疾患の有病率の増加、老人人口の増加、およびポイントオブケア（POC）検査およびデバイスの需要の増加によって集合的に推進されています。
高齢者に対応するために家庭やその他の医療現場でPOC機器の需要が高まっていることや、外来診療モデルを確立して入院期間を短縮するための政府の取り組みが増加していることが、今後6年間のPOC診断の需要を牽引すると予想されます。バイオテクノロジー業界の成長は、革新的な新製品の発売、合意、買収、技術の進歩、さまざまな用途での採用の増加など、いくつかの要因にも起因しています。
例えば、2021年1月、Sartorius Stedim Biotech社はNovasep社のクロマトグラフィープロセス機器部門を買収しました。同社のクロマトグラフィー製品ポートフォリオは、オリゴヌクレオチド、低分子、インスリン、ペプチドなどの多目的アプリケーション向けの強化クロマトグラフィーシステムと樹脂ベースのバッチで構成されています。
また、下流工程を迅速に行うための新製品が各社から発売されています。例えば、Waters Corporation社は2021年2月、次世代液体クロマトグラフィーシステム「Waters ACQUITY PREMIER Solution」を発表しました。同社の画期的な技術である「MaxPeak High-performance Surface」を搭載しています。手間のかかる工程を省き、分析データの質を向上させるなどのメリットがあります。
目次
Table of Contents
Chapter 1 Methodology and Scope
1.1 Research Methodology
1.2 Research Assumptions
1.2.1 Estimates and Forecast Timeline
1.3 Research Methodology
1.4 Information Procurement
1.4.1 Purchased Database
1.4.2 GVR’s Internal Database
1.4.3 Secondary Sources
1.4.4 Primary Research
1.4.4.1 Primary Sources:
1.4.4.2 Secondary Data Sources:
1.5 Information or Data Analysis
1.5.1 Data Analysis Models
1.6 Market Formulation & Validation
1.7 Market Model
1.7.1 Model Details
1.7.1.1 Nucleic Acid Preparation market
1.7.2 Cell biology market
1.7.2.1 Comparison of 3D cell culture techniques
1.7.3 Revenue share assessment of end use
1.8 Objectives
1.8.1 Objective 1:
1.8.2 Objective 2:
Chapter 2 Executive Summary
2.1 Market Summary
Chapter 3 Market Variables, Trends, & Scope
3.1 Market Segmentation
3.2 Market Dynamics
3.2.1 Market driver analysis
3.2.1.1 Increasing demand for Point-of-care (POC) tests and devices
3.2.1.2 Growing prevalence of target diseases and rising geriatric population
3.2.1.3 Advantages offered by laser therapy
3.2.1.4 Technological advancements
3.2.2 Market restraint analysis
3.2.2.1 Higher cost of devices
3.2.2.2 shortage of skilled professionals
3.2.3 Market opportunity analysis
3.2.3.1 Rise in the demand for biotechnology instruments and life sciences consumables after COVID-19 outbreak
3.2.4 Market threat analysis
3.2.4.1 regulatory gaps and hurdles
3.3 Penetration and Growth Prospect Mapping for Technology, 2020 (USD Million)
3.4 Business Environment Analysis
3.4.1 SWOT Analysis; By factor (Political & Legal, Economic, and Technological)
3.4.2 Porter’s Five Forces Analysis
3.5 Competitive Landscape
3.5.1 Established players
3.5.2 Emerging players & funding Outlook
Chapter 4 Product Business Analysis
4.1 Market: Product Movement Analysis
4.2 Lab Automation Instruments
4.2.1 Market, 2017 - 2028 (USD Million)
4.2.2 By Application
4.2.2.1 Proteomics
4.2.2.1.1 Market for proteomics, 2017 - 2028 (USD Million)
4.2.2.2 Genomics
4.2.2.2.1 Market for genomics, 2017 - 2028 (USD Million)
4.2.2.3 Sequencing
4.2.2.3.1 Market for sequencing, 2017 - 2028 (USD Million)
4.2.2.4 Spatial Cell Analysis
4.2.2.4.1 Market for spatial cell analysis, 2017 - 2028 (USD Million)
4.2.2.5 Others
4.2.2.5.1 Market for other applications, 2017 - 2028 (USD Million)
4.3 Life Science Consumables
4.3.1 Market, 2017 - 2028 (USD Million)
4.4 IVD Instruments
4.4.1 Market, 2017 - 2028 (USD Million)
4.5 Medical Lasers
4.5.1 Market, 2017 - 2028 (USD Million)
4.5.2 By Application
4.5.2.1 Therapeutics
4.5.2.1.1 Market for therapeutics, 2017 - 2028 (USD Million)
4.5.2.2 Ophthalmics
4.5.2.2.1 Market for ophthalmics, 2017 - 2028 (USD Million)
4.5.2.3 Ablation
4.5.2.3.1 Market for ablation, 2017 - 2028 (USD Million)
Chapter 5 End-use Business Analysis
5.1 Market: End-use Movement Analysis
5.2 Government & Academic Institutes
5.2.1 Market for government & academic Institutes, 2017 - 2028 (USD Million)
5.3 Pharmaceutical & Biotechnology Companies
5.3.1 Market for pharmaceutical & biotechnology companies, 2017 - 2028 (USD Million)
5.4 Hospitals & Healthcare Facilities
5.4.1 Market for hospitals & healthcare facilities, 2017 - 2028 (USD Million)
5.5 Others
5.5.1 Market for Other end use, 2017 - 2028 (USD Million)
Chapter 6 Regional Business Analysis
6.1 Market Share by Regional, 2020 & 2028
6.2 North America
6.2.1 North America biotechnology instruments market, 2017 - 2028 (USD Million)
6.2.2 U.S.
6.2.2.1 U.S. biotechnology instruments market, by product, 2017 - 2028 (USD Million)
6.2.2.2 U.S. biotechnology instruments market, by end use, 2017 - 2028 (USD Million)
6.2.3 Canada
6.2.3.1 Canada biotechnology instruments market, by product, 2017 - 2028 (USD Million)
6.2.3.2 Canada biotechnology instruments market, by end use, 2017 - 2028 (USD Million)
6.3 Europe
6.3.1 Europe biotechnology instruments market, 2017-2028 (USD Million)
6.3.2 Germany
6.3.2.1 Germany biotechnology instruments market, by product, 2017 - 2028 (USD Million)
6.3.2.2 Germany biotechnology instruments market, by end use, 2017 - 2028 (USD Million)
6.3.3 U.K.
6.3.3.1 U.K. biotechnology instruments market, by product, 2017 - 2028 (USD Million)
6.3.3.2 U.K. biotechnology instruments market, by end use, 2017 - 2028 (USD Million)
6.3.4 France
6.3.4.1 France biotechnology instruments market, by product, 2017 - 2028 (USD Million)
6.3.4.2 France biotechnology instruments market, by end use, 2017 - 2028 (USD Million)
6.3.5 Italy
6.3.5.1 Italy biotechnology instruments market, by product, 2017 - 2028 (USD Million)
6.3.5.2 Italy biotechnology instruments market, by end use, 2017 - 2028 (USD Million)
6.3.6 Spain
6.3.6.1 Spain biotechnology instruments market, by product, 2017 - 2028 (USD Million)
6.3.6.2 Spain biotechnology instruments market, by end use, 2017 - 2028 (USD Million)
6.4 Asia Pacific
6.4.1 Asia Pacific biotechnology instruments market, 2017-2028 (USD Million)
6.4.2 Japan
6.4.2.1 Japan biotechnology instruments market, by product, 2017 - 2028 (USD Million)
6.4.2.2 Japan biotechnology instruments market, by end use, 2017 - 2028 (USD Million)
6.4.3 China
6.4.3.1 China biotechnology instruments market, by product, 2017 - 2028 (USD Million)
6.4.3.2 China biotechnology instruments market, by end use, 2017 - 2028 (USD Million)
6.4.4 India
6.4.4.1 India biotechnology instruments market, by product, 2017 - 2028 (USD Million)
6.4.4.2 India biotechnology instruments market, by end use, 2017 - 2028 (USD Million)
6.5 Latin America
6.5.1 Latin America biotechnology instruments market, 2017-2028 (USD Million)
6.5.2 Brazil
6.5.2.1 Brazil biotechnology instruments market, by product, 2017 - 2028 (USD Million)
6.5.2.2 Brazil biotechnology instruments market, by end use, 2017 - 2028 (USD Million)
6.5.3 Mexico
6.5.3.1 Mexico biotechnology instruments market, by product, 2017 - 2028 (USD Million)
6.5.3.2 Mexico biotechnology instruments market, by end use, 2017 - 2028 (USD Million)
6.6 Middle East and Africa (MEA)
6.6.1 MEA biotechnology instruments market, 2017-2028 (USD Million)
6.6.2 South Africa
6.6.2.1 South Africa biotechnology instruments market, by product, 2017 - 2028 (USD Million)
6.6.2.2 South Africa biotechnology instruments market, by end use, 2017 - 2028 (USD Million)
6.6.3 Saudi Arabia
6.6.3.1 Saudi Arabia biotechnology instruments market, by product, 2017 - 2028 (USD Million)
6.6.3.2 Saudi Arabia biotechnology instruments market, by end use, 2017 - 2028 (USD Million)
Chapter 7 Competitive Landscape
7.1 Company Profiles: Medical Lasers Market
7.1.1 Alcon, Inc.
7.1.1.1 Company overview
7.1.1.2 Financial Performance
7.1.1.3 Product benchmarking
7.1.1.4 Strategic initiatives
7.1.2 AngioDynamics
7.1.2.1 Company overview
7.1.2.2 Financial Performance
7.1.2.3 Product benchmarking
7.1.2.4 Strategic initiatives
7.1.3 Cynosure, LLC
7.1.3.1 Company overview
7.1.3.2 Financial Performance
7.1.3.3 Product benchmarking
7.1.4 Lumenis
7.1.4.1 Company overview
7.1.4.2 Financial performance
7.1.4.3 Product benchmarking
7.1.4.4 Strategic initiatives
7.1.5 Candela Medical
7.1.5.1 Company overview
7.1.5.2 Financial performance
7.1.5.3 Product benchmarking
7.1.5.4 Strategic initiatives
7.1.6 Novanta, Inc.
7.1.6.1 Company overview
7.1.6.2 Financial Performance
7.1.6.3 Product benchmarking
7.1.6.4 Strategic initiatives
7.1.7 Iridex
7.1.7.1 Company overview
7.1.7.2 Financial Performance
7.1.7.3 Product benchmarking
7.1.7.4 Strategic initiatives
7.1.8 Zimmer Biomet
7.1.8.1 Company overview
7.1.8.2 Zimmer MedizinSysteme GmbH
7.1.8.3 Financial Performance
7.1.8.4 Product benchmarking
7.2 Company Profiles: Lab Automation Market
7.2.1 Endress+Hauser
7.2.1.1 Company overview
7.2.1.2 Analytik Jena GmbH
7.2.1.3 Financial Performance
7.2.1.3.1 Financial Performance (Analytik Jena GmbH)
7.2.1.4 Product benchmarking
7.2.1.5 Strategic initiatives
7.2.2 Tecan Trading AG
7.2.2.1 Company overview
7.2.2.2 Financial Performance
7.2.2.3 Product benchmarking
7.2.2.4 Strategic initiatives
7.2.3 F. Hoffmann-La Roche Ltd.
7.2.3.1 Company overview
7.2.3.2 Financial Performance
7.2.3.3 Product benchmarking
7.2.3.4 Strategic initiatives
7.2.4 Danaher Corporation
7.2.4.1 Company overview
7.2.4.1.1.1 Beckman Coulter, Inc.
7.2.4.2 Financial performance
7.2.4.3 Product benchmarking
7.2.4.4 Strategic initiatives
7.2.5 Perkin Elmer
7.2.5.1 Company overview
7.2.5.2 Financial performance
7.2.5.3 Product benchmarking
7.2.5.4 Strategic initiatives
7.2.6 Waters Corporation
7.2.6.1 Company overview
7.2.6.2 Financial Performance
7.2.6.3 Product benchmarking
7.2.6.4 Strategic initiatives
7.2.7 Thermo Fisher Scientific, Inc.
7.2.7.1 Company overview
7.2.7.2 Financial Performance
7.2.7.3 Product benchmarking
7.2.7.4 Strategic initiatives
7.2.8 BioTek Instruments, Inc.
7.2.8.1 Company overview
7.2.8.2 Financial performance
7.2.8.3 Product BenchmarkinG
7.2.8.4 Strategic Initiatives
7.3 Company Profiles: Life Science Consumables Market
7.3.1 QIAGEN
7.3.1.1 Company overview
7.3.1.2 INGENUITY
7.3.1.2.1 Company overview
7.3.1.3 CLC BIO
7.3.1.3.1 Company overview
7.3.1.4 Financial Performance
7.3.1.5 Product benchmarking
7.3.1.6 Strategic initiatives
7.3.2 Merck KGaA
7.3.2.1 Company overview
7.3.2.2 SIGMA-ALDRICH INC.
7.3.2.2.1 Company overview
7.3.2.3 MERCK MILLIPORE
7.3.2.3.1 Company overview
7.3.2.4 Financial Performance
7.3.2.5 Product benchmarking
7.3.2.6 Strategic initiatives
7.3.3 Thermo Fisher Scientific, Inc.
7.3.3.1 Company overview
7.3.3.2 LIFE TECHNOLOGIES CORP
7.3.3.3 Financial Performance
7.3.3.4 Product benchmarking
7.3.3.5 Strategic initiatives
7.3.4 Illumina, Inc.
7.3.4.1 Company overview
7.3.4.2 Financial performance
7.3.4.3 Product benchmarking
7.3.4.4 Strategic initiatives
7.3.5 Becton, Dickinson and Company (BD)
7.3.5.1 Company overview
7.3.5.2 Financial performance
7.3.5.3 Product benchmarking
7.3.5.4 Strategic initiatives
7.3.6 Agilent Technologies
7.3.6.1 Company overview
7.3.6.2 Financial Performance
7.3.6.3 Product benchmarking
7.3.6.4 Strategic initiatives
7.3.7 Bio-Rad Laboratories, Inc.
7.3.7.1 Company overview
7.3.7.2 GnuBio
7.3.7.2.1 Company overview
7.3.7.3 Financial Performance
7.3.7.4 Product benchmarking
7.3.7.5 Strategic initiatives
7.4 Company Profiles: IVD Instruments Market
7.4.1 F. Hoffmann-La Roche AG
7.4.1.1 Company overview
7.4.1.2 Financial Performance
7.4.1.3 Product benchmarking
7.4.1.4 Strategic initiatives
7.4.2 Agilent Technologies
7.4.2.1 Company overview
7.4.2.2 Financial Performance
7.4.2.3 Product benchmarking
7.4.2.4 Strategic initiatives
7.4.3 Danaher Corporation
7.4.3.1 Company overview
7.4.3.2 Financial Performance
7.4.3.3 Product benchmarking
7.4.3.4 Strategic initiatives
7.4.4 Abbott
7.4.4.1 Company overview
7.4.4.2 Financial performance
7.4.4.3 Product benchmarking
7.4.4.4 Strategic initiatives
7.4.5 bioMérieux SA
7.4.5.1 Company overview
7.4.5.2 Financial performance
7.4.5.3 Product benchmarking
7.4.5.4 Strategic initiatives
7.4.6 Bio-Rad Laboratories, Inc.
7.4.6.1 Company overview
7.4.6.2 Financial Performance
7.4.6.3 Product benchmarking
7.4.6.4 Strategic initiatives
7.4.7 Becton, Dickinson and Company
7.4.7.1 Company overview
7.4.7.2 Financial Performance
7.4.7.3 Product benchmarking
7.4.7.4 Strategic initiatives
7.4.8 Siemens Healthineers AG
7.4.8.1 Company overview
7.4.8.2 Financial Performance
7.4.8.3 Product benchmarking
7.4.8.4 Strategic initiatives
List of Tables
Table 1 Automated systems to isolate DNA/RNA
Table 2 Established Key Players
Table 3 Funding outlook: IVD market
Table 4 Funding outlook: Life Sciences Platforms and Tools
Table 5 Funding outlook: Medical lasers
Table 6 Funding outlook: Lab automation
Table 7 Some of the prominent commercial RT-PCR kits for COVID-19 detection
Table 8 North America Biotechnology Instruments Market, by Product, 2017 - 2028 (USD Million)
Table 9 North America Lab Automation Instruments Market, by Application, 2017 - 2028 (USD Million)
Table 10 North America Medical Lasers Market, by Application, 2017 - 2028 (USD Million)
Table 11 North America Biotechnology Instruments Market, by End Use, 2017 - 2028 (USD Million)
Table 12 U.S. Biotechnology Instruments Market, by Product, 2017 - 2028 (USD Million)
Table 13 U.S. Lab Automation Instruments Market, by Application, 2017 - 2028 (USD Million)
Table 14 U.S. Medical Lasers Market, by Application, 2017 - 2028 (USD Million)
Table 15 U.S. Biotechnology Instruments Market, by End Use, 2017 - 2028 (USD Million)
Table 16 Canada Biotechnology Instruments Market, by Product, 2017 - 2028 (USD Million)
Table 17 Canada Lab Automation Instruments Market, by Application, 2017 - 2028 (USD Million)
Table 18 Canada Medical Lasers Market, by Application, 2017 - 2028 (USD Million)
Table 19 Canada Biotechnology Instruments Market, by End Use, 2017 - 2028 (USD Million)
Table 20 Europe Biotechnology Instruments Market, by Product, 2017 - 2028 (USD Million)
Table 21 Europe Lab Automation Instruments Market, by Application, 2017 - 2028 (USD Million)
Table 22 Europe Medical Lasers Market, by Application, 2017 - 2028 (USD Million)
Table 23 Europe Biotechnology Instruments Market, by End Use, 2017 - 2028 (USD Million)
Table 24 Germany Biotechnology Instruments Market, by Product, 2017 - 2028 (USD Million)
Table 25 Germany Lab Automation Instruments Market, by Application, 2017 - 2028 (USD Million)
Table 26 Germany Medical Lasers Market, by Application, 2017 - 2028 (USD Million)
Table 27 Germany Biotechnology Instruments Market, by End Use, 2017 - 2028 (USD Million)
Table 28 France Biotechnology Instruments Market, by Product, 2017 - 2028 (USD Million)
Table 29 France Lab Automation Instruments Market, by Application, 2017 - 2028 (USD Million)
Table 30 France Medical Lasers Market, by Application, 2017 - 2028 (USD Million)
Table 31 France Biotechnology Instruments Market, by End Use, 2017 - 2028 (USD Million)
Table 32 U.K. Biotechnology Instruments Market, by Product, 2017 - 2028 (USD Million)
Table 33 U.K. Lab Automation Instruments Market, by Application, 2017 - 2028 (USD Million)
Table 34 U.K. Medical Lasers Market, by Application, 2017 - 2028 (USD Million)
Table 35 U.K. Biotechnology Instruments Market, by End Use, 2017 - 2028 (USD Million)
Table 36 Italy Biotechnology Instruments Market, by Product, 2017 - 2028 (USD Million)
Table 37 Italy Lab Automation Instruments Market, by Application, 2017 - 2028 (USD Million)
Table 38 Italy Medical Lasers Market, by Application, 2017 - 2028 (USD Million)
Table 39 Italy Biotechnology Instruments Market, by End Use, 2017 - 2028 (USD Million)
Table 40 Spain Biotechnology Instruments Market, by Product, 2017 - 2028 (USD Million)
Table 41 Spain Lab Automation Instruments Market, by Application, 2017 - 2028 (USD Million)
Table 42 Spain Medical Lasers Market, by Application, 2017 - 2028 (USD Million)
Table 43 Spain Biotechnology Instruments Market, by End Use, 2017 - 2028 (USD Million)
Table 44 Asia Pacific Biotechnology Instruments Market, by Product, 2017 - 2028 (USD Million)
Table 45 Asia Pacific Lab Automation Instruments Market, by Application, 2017 - 2028 (USD Million)
Table 46 Asia Pacific Medical Lasers Market, by Application, 2017 - 2028 (USD Million)
Table 47 Asia Pacific Biotechnology Instruments Market, by End Use, 2017 - 2028 (USD Million)
Table 48 Japan Biotechnology Instruments Market, by Product, 2017 - 2028 (USD Million)
Table 49 Japan Lab Automation Instruments Market, by Application, 2017 - 2028 (USD Million)
Table 50 Japan Medical Lasers Market, by Application, 2017 - 2028 (USD Million)
Table 51 Japan Biotechnology Instruments Market, by End Use, 2017 - 2028 (USD Million)
Table 52 China Biotechnology Instruments Market, by Product, 2017 - 2028 (USD Million)
Table 53 China Lab Automation Instruments Market, by Application, 2017 - 2028 (USD Million)
Table 54 China Medical Lasers Market, by Application, 2017 - 2028 (USD Million)
Table 55 China Biotechnology Instruments Market, by End Use, 2017 - 2028 (USD Million)
Table 56 India Biotechnology Instruments Market, by Product, 2017 - 2028 (USD Million)
Table 57 India Lab Automation Instruments Market, by Application, 2017 - 2028 (USD Million)
Table 58 India Medical Lasers Market, by Application, 2017 - 2028 (USD Million)
Table 59 India Biotechnology Instruments Market, by End Use, 2017 - 2028 (USD Million)
Table 60 Latin America Biotechnology Instruments Market, by Product, 2017 - 2028 (USD Million)
Table 61 Latin America Lab Automation Instruments Market, by Application, 2017 - 2028 (USD Million)
Table 62 Latin America Medical Lasers Market, by Application, 2017 - 2028 (USD Million)
Table 63 Latin America Biotechnology Instruments Market, by End Use, 2017 - 2028 (USD Million)
Table 64 Brazil Biotechnology Instruments Market, by Product, 2017 - 2028 (USD Million)
Table 65 Brazil Lab Automation Instruments Market, by Application, 2017 - 2028 (USD Million)
Table 66 Brazil Medical Lasers Market, by Application, 2017 - 2028 (USD Million)
Table 67 Brazil Biotechnology Instruments Market, by End Use, 2017 - 2028 (USD Million)
Table 68 Mexico Biotechnology Instruments Market, by Product, 2017 - 2028 (USD Million)
Table 69 Mexico Lab Automation Instruments Market, by Application, 2017 - 2028 (USD Million)
Table 70 Mexico Medical Lasers Market, by Application, 2017 - 2028 (USD Million)
Table 71 Mexico Biotechnology Instruments Market, by End Use, 2017 - 2028 (USD Million)
Table 72 MEA Biotechnology Instruments Market, by Product, 2017 - 2028 (USD Million)
Table 73 MEA Lab Automation Instruments Market, by Application, 2017 - 2028 (USD Million)
Table 74 MEA Medical Lasers Market, by Application, 2017 - 2028 (USD Million)
Table 75 MEA Biotechnology Instruments Market, by End Use, 2017 - 2028 (USD Million)
Table 76 South Africa Biotechnology Instruments Market, by Product, 2017 - 2028 (USD Million)
Table 77 South Africa Lab Automation Instruments Market, by Application, 2017 - 2028 (USD Million)
Table 78 South Africa Medical Lasers Market, by Application, 2017 - 2028 (USD Million)
Table 79 South Africa Biotechnology Instruments Market, by End Use, 2017 - 2028 (USD Million)
Table 80 Saudi Arabia Biotechnology Instruments Market, by Product, 2017 - 2028 (USD Million)
Table 81 Saudi Arabia Lab Automation Instruments Market, by Application, 2017 - 2028 (USD Million)
Table 82 Saudi Arabia Medical Lasers Market, by Application, 2017 - 2028 (USD Million)
Table 83 Saudi Arabia Biotechnology Instruments Market, by End Use, 2017 - 2028 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Methodology
Fig. 9 Biotechnology instruments market estimation process
Fig. 10 Analysis of individual products for global market modeling
Fig. 11 Life science consumables scope, by technology
Fig. 12 Ancillary market analysis
Fig. 13 Genetic analysis techniques market share analysis
Fig. 14 Commodity flow analysis modeling for nucleic acid preparation market
Fig. 15 Comparison of 3D cell culture techniques
Fig. 16 Commodity flow analysis
Fig. 17 Market snapshot (USD Million)
Fig. 18 Market segmentation & scope
Fig. 19 Market trends and outlook
Fig. 20 Market driver impact
Fig. 21 Key benefits of POC devices
Fig. 22 Saving related to the implementation of POC testing
Fig. 23 World age-standardized prevalence of diabetes, ages 20-79 years, by region
Fig. 24 Global percentage of the population, by age group, 2000 and 2050
Fig. 25 Population over the age of 65 years, by region, 2010 and 2050
Fig. 26 Benefits of laser therapy
Fig. 27 Biological effects of laser therapy
Fig. 28 Market restraint impact
Fig. 29 Penetration and growth prospect mapping
Fig. 30 SWOT analysis, by factor (Political & legal, economic, and technological)
Fig. 31 Porter’s Five Forces Analysis
Fig. 32 Biotechnology instruments market: Product outlook and key takeaways
Fig. 33 Automated hardware & equipment currently used in laboratories
Fig. 34 Biotechnology instruments market: Product movement analysis
Fig. 35 Global biotechnology lab automation instruments market, 2017 - 2028 (USD Million)
Fig. 36 Global biotechnology lab automation instruments market for proteomics, 2017 - 2028 (USD Million)
Fig. 37 Diverse genomic applications of automated workstation: PerkinElmer Inc.
Fig. 38 Global biotechnology lab automation instruments market for genomics, 2017 - 2028 (USD Million)
Fig. 39 NGS library preparation automation strategies: Sequencing centers
Fig. 40 Global biotechnology lab automation instruments market for sequencing, 2017 - 2028 (USD Million)
Fig. 41 Global biotechnology lab automation instruments market for spatial cell analysis, 2017 - 2028 (USD Million)
Fig. 42 Global biotechnology lab automation instruments market for other applications, 2017 - 2028 (USD Million)
Fig. 43 Global biotechnology life science consumables market, 2017 - 2028 (USD Million)
Fig. 44 Factors contributing to the growth of the IVD instruments
Fig. 45 Global biotechnology IVD instruments market, 2017 - 2028 (USD Million)
Fig. 46 Global biotechnology medical lasers market, 2017 - 2028 (USD Million)
Fig. 47 Global biotechnology medical lasers market for therapeutics, 2017 - 2028 (USD Million)
Fig. 48 Global biotechnology medical lasers market for ophthalmics, 2017 - 2028 (USD Million)
Fig. 49 Global biotechnology medical lasers market for ablation, 2017 - 2028 (USD Million)
Fig. 50 Biotechnology instruments market: End-use outlook and key takeaways
Fig. 51 Biotechnology instruments market: End-use movement analysis
Fig. 52 Biotechnology instruments market for government & academic institutes, 2017 - 2028 (USD Million)
Fig. 53 Biotechnology instruments market for pharmaceutical & biotechnology companies, 2017 - 2028 (USD Million)
Fig. 54 Biotechnology instruments market for hospitals & healthcare facilities, 2017 - 2028 (USD Million)
Fig. 55 Biotechnology instruments market for other end uses, 2017 - 2028 (USD Million)
Fig. 56 Biotechnology instruments market: Regional outlook and key takeaways
Fig. 57 Biotechnology instruments market: Regional outlook, 2020 & 2028
Fig. 58 North America biotechnology instruments market, 2017 - 2028 (USD Million)
Fig. 59 Europe biotechnology instruments market, 2017 - 2028 (USD Million)
Fig. 60 Asia Pacific biotechnology instruments market, 2017 - 2028 (USD Million)
Fig. 61 Latin America biotechnology instruments market, 2017 - 2028 (USD Million)
Fig. 62 MEA biotechnology instruments market, 2017 - 2028 (USD Million)
Fig. 63 U.S. biotechnology instruments market, 2017 - 2028 (USD Million)
Fig. 64 Canada biotechnology instruments market, 2017 - 2028 (USD Million)
Fig. 65 Germany biotechnology instruments market, 2017 - 2028 (USD Million)
Fig. 66 U.K. biotechnology instruments market, 2017 - 2028 (USD Million)
Fig. 67 France biotechnology instruments market, 2017 - 2028 (USD Million)
Fig. 68 Italy biotechnology instruments market, 2017 - 2028 (USD Million)
Fig. 69 Spain biotechnology instruments market, 2017 - 2028 (USD Million)
Fig. 70 Japan biotechnology instruments market, 2017 - 2028 (USD Million)
Fig. 71 China biotechnology instruments market, 2017 - 2028 (USD Million)
Fig. 72 India biotechnology instruments market, 2017 - 2028 (USD Million)
Fig. 73 Brazil biotechnology instruments market, 2017 - 2028 (USD Million)
Fig. 74 Mexico biotechnology instruments market, 2017 - 2028 (USD Million)
Fig. 75 Saudi Arabia biotechnology instruments market, 2017 - 2028 (USD Million)
Fig. 76 South Africa biotechnology instruments market, 2017 - 2028 (USD Million)
